High Grade Gliomas: Clinical Trials

7 trials for High Grade Gliomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 1 completed, 1 not yet recruiting. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Recruiting 5, Completed 1, Not yet recruiting 1
Phase 22Recruiting 2

Follow High Grade Gliomas: new trials by email Literature Review of High Grade Gliomas trials Research Report on High Grade Gliomas

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas
Phase 1RecruitingChildren's National Research Institute302026-09-012026-09-09
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
Rhenium-186 Nanoliposome - Ependymoma, High Grade Gliomas
Phase 1RecruitingCerenome562026-08-012026-09-11
Preoperative Proton Irradiation for High-grade Brain Gliomas.
Preoperative irradiation - High Grade Gliomas
Phase 1RecruitingNational Medical Research Radiological Centre of the Ministry of Health of Russia92026-07-012026-07-17
Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor
Gallium maltolate - High Grade Gliomas, Atypical Teratoid Rhabdoid Tumors (ATRT)
Phase 1Not yet recruitingSarah Rumler152026-05-152026-01-09
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
TGX-007, Valaciclovir - Glioblastoma (GBM), High Grade Gliomas
Phase 1 / Phase 2RecruitingTrogenix ltd682026-04-212026-10-23
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Olaparib; 177Lu-DOTATATE - Solid Tumor Cancer, Medulloblastoma
Phase 1 / Phase 2RecruitingFundación de investigación HM252024-09-202026-06-04
SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas
SM-1,TMZ - Glioma, Glioblastomas (GBM)
Phase 1CompletedShenzhen Zhenxing Medical Technology Co., Ltd352022-09-192026-06-09

Narrower conditions

Glioma (4)  ·  Glioblastoma (3)  ·  Brain Neoplasms (2)  ·  Diffuse Intrinsic Pontine Glioma (2)  ·  Ependymoma (2)  ·  Recurrence (2)  ·  Rhabdoid Tumor (2)  ·  Adrenal Cortex Neoplasms (1)  ·  Adrenal Gland Neoplasms (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Medulloblastoma (1)  ·  Meningioma (1)  ·  Neuroblastoma (1)  ·  Neuroendocrine Tumors (1)  ·  Osteosarcoma (1)

Broader conditions

Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Neoplasms, Nerve Tissue (6)  ·  Neoplasms, Neuroepithelial (6)  ·  Neuroectodermal Tumors (6)  ·  Astrocytoma (3)  ·  Central Nervous System Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Brain Diseases (2)  ·  Brain Stem Neoplasms (2)  ·  Central Nervous System Diseases (2)

Interventions

Nivolumab (1)  ·  Valacyclovir (1)  ·  gallium maltolate (1)  ·  lutetium Lu 177 dotatate (1)  ·  olaparib (1)

Sponsors

Cerenome (1)  ·  Children's National Research Institute (1)  ·  Fundación de investigación HM (1)  ·  National Medical Research Radiological Centre of the Ministry of Health of Russia (1)  ·  Sarah Rumler (1)  ·  Shenzhen Zhenxing Medical Technology Co., Ltd (1)  ·  Trogenix ltd (1)

Countries

United States (3)  ·  China (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alexey Goryanov (1)  ·  Igor Gulidov (1)  ·  Marta Osuna Marco, PhD (1)